Adhera Therapeutics, Inc. Fair Value, Net Asset (Liability)
Adhera Therapeutics, Inc. had Fair Value, Net Asset (Liability) of $0 as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:FairValueNetAssetLiability · last filed 2023-03-31
- 2022-12-31: Fair Value, Net Asset (Liability) $0.00.
- 2022-09-30: Fair Value, Net Asset (Liability) $0.00.
- 2022-06-30: Fair Value, Net Asset (Liability) $0.00.
- 2022-03-31: Fair Value, Net Asset (Liability) $0.00.
| Period end | Fair Value, Net Asset (Liability) |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-22 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-23 |
| 2020-12-31 | $0.00 10-K · filed 2022-04-15 |